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Syndecans are a family of four cell surface proteogly-
cans that bind to various components of the extracel-
lular environment and can regulate many cellular 
behaviors including growth, adhesion, and move-
ment. To determine whether syndecans can function 
during wound repair, we have examined expression 
of the syndecans during wound repair of adult mouse 
and neonatal or fetal human skin. Syndecan-l and-4 
were induced in the dermis within 12 h after inci-
sional injury of murine or neonatal human skin. 
Syndecan-1 was induced primarily on endothelium, 
and syndecan-4 was present throughout the dermis at 
the site of injury. Following re-epithelialization, ex-
pression of the syndecans return to their baseline 
level. In marked contrast to these observations , 
H epa ran sul fate proteogIycans (HSPGs) bind and influence the fun ction of mul tipl e effec to r m ole-cules such as growth factors and cytokines, matrix adhesio n m olecul es, insoluble components of tbe extracellul ar matrix, proteases, and protease inhib-
itors (Ruoslahti and Yamaguch.i, 1991; Rapraeger, 1993) . Each of 
th ese molecul es has been shown to be active during wound repair. 
Thus, a ch ange in expression of HSPGs may control the action of 
many heparin-bind ing molecules and the cellular behaviors they 
influence in the wound . 
T he HSPGs can be found at the basem ent membrane, in the 
in terstitia l matrix, intracellul arly, and at the ceLl surface. Cell 
surface HS mostl y represents one o r m ore of the four members of 
the syndecan fam i.l y of transm embrane proteoglyc3ns (Bern field cf 
ai, 1992; R apraeger, 1993) . All adh erent ce lls express syndecans, 
and the re lative amount of each of the fa mily members is specific 
for cell and tissue type (Kim c/ ai, 1994). Syndecans are evolution-
ary conserved molecules. found in Drosophila (Spring ef ai, 1994), 
Xellopus (Rosenblum ef ai, 1995), avian (Gould cf ai, 1992; Baciu cf 
ai, 1994), and mammalian species incl udin g mice, rats, and humans. 
During embryoni c developmen t the expression of the syndecans 
changes coincident w ith a change in ce ll phenotype (Thesleff ef ai, 
1988; Solursh ef ai, 1990; Gould ef (/1, 1992; Bern fie ld et ai, 1993 ; 
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wounded human fetal skin showed no increase in 
expression of syndecans. This lack of increase in the 
expression o f syndecans by cells of the dermis corre-
lates with prior observations that fetal skin heals 
without a polymorphonuclear cell infiltrate, appre-
ciable fibrosis, or clinically apparent scar. Thus, in-
duced expression of syndecans is not an absolute 
requirement for wound repair but does correlate with 
the occurrence of fibrosis in mature skin. These 
findings support the role ofsyndecans as regulators of 
cell behavior and suggest that syndecan-l and - 4 
induction in the dermis may contribute to events that 
lead to inflammation and fibrosis. Key words: proteo-
glycalls//repa.Ya.1l su/fate/glycosamillog1ycans/wolllld heali"g. 
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David ef ai, 1993). In cultured cells a change in syndecan expression 
modulates cell behavior. A decrease in ce Ll surnlce syndecau-l by 
transfection with anti - sense constru cts induces epithelial cells to 
become fusiform in morphology (Kato ef ai, 1995) . Conversely, 
ce lJ s with a fusiform morph ology that increase syndecan-1 adopt a 
morc epithelial-li ke phenotype (Leppa et ai, 1992; Carey et ai, 
1994). T hese observations, combined with their widespread distri-
bution , evolution ary conservation, and stric tly controlled develop-
mental expression, suggest that syndecans can control cell beha -
lor . 
Since wound repair requires coordination of multiple cell behav-
iors, we wished to learn w hether the expressio n of syndecans 
changes during the response to injury. We evaluated expression of 
syndecans folJowing injury to mouse, neonatal human, and fetal 
human skin . T his approach permitted comparison between species 
as well as between neonata l and feta l skin . After injury, we find a 
large and transient increase in syndecan- 1 and syndecan-4 in tile 
derm is of the m o use and neonatal human skin but n o chan ge in 
syndecans expressed in feta l skin. T his difference in the abili ty of 
these tissues to increase syn decan expression correlates with obser-
vations that fetal skin heals without fibrosis or detectable scarring. 
Syndecans may bind molecul es th at can increase inflammation and 
tibrosis. T here fore, these findings further our understanding of 
m o lecular events that occur during wound repair and present au 
intliguing h ypothesis to explain di ffe rences in the response of fetal 
and adult skin to injury. 
M ATER.IALS AND METHODS 
Cell Culture and Conditioned Media Preparation A proteogl)'can 
fraction from conditioned medium was purified from the human lung 
t1broblast cell line IMR.-90 (ATCC No. CCl 186) by modi fication of 
procedures as described previously (R.ap raegcr and Bernfield , 1985). 
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Briefly, m edium from confluent cell cultures was m odifi ed to contain a final 
concentration of 50 n1.M sod ium acetate, pH 4.5, 2 M urea, and 1 % Triton 
X100. This so lution was absorbed to QAE-Sephadex (Pharmacia , P iscat-
away, N]) and washed with acetate-urea buffer containing 150 111 M and 300 
mM NaCl, success ively. Tota l proteoglycan was elu ted with 2 M NaCI in 
ace tate-urea buffer. 
Cloning of Human Syndecan-l and -4 and Expression as Fusion 
P roteins Partial clones of human syndccan-l and -4 were obtained by the 
polynlerasc chain reaction (PCR) using oligonucleotides designed fo r usc in 
the pGEX- 2T expression system (described below). For syndecan-l, the 
5 ' - o ligonucleotide (5' - ATGAA TTCTGTCCAGGAGGCCCTGTGAG-3') 
spans POSIl:IOns 257- 279 and the 3'-0 Iigonucleotide (5' -ATGAAT-
TCAGCTGGCCCTGCCGCAAATTG-3') spans positions 931-950 of the 
previously determined human e xtracellular sequence (Mali el nl, 1990). For 
synd ecan-4, the S'-oligonucleotide (5' - GAGTCGATTCGAGAGACTGA-
3') spans positions 85-104, and the 3' -0 Ii gonucleotide (S' - GCGAATTCT-
TATCTTTCAAAAATGTTG-3') spans pos itions 434 - 456 of the previ-
ously d etermined rat extrace llular sequence (Kojima ct nl, 1992b). 
Each set of oligonucleotides we re used as primers in PCR reactions using 
cDNA derived from 21. - wk gestation human lung tissue. Single products 
were o btained corresponding to approxi ma tely 700 bp for syndecan-1 and 
approximately 370 bp for syndecan-4. PC R. prod ucts w ere isolated from 
SeaKem agarose gels (FMC, Rockland, ME) and purified by centrifugation 
through Spin X columns (C ostar, Cambridge, MA). 
DNAs were digested w ith EcoRI and Bnllll-ll to obtain cohesive ends 
sui ta ble for subcloning into the pGEX-2T vector (Pharmacia Uppsala. 
Sweden) . Partial sequence of the cloned inserts confirmed their identity 
based o n the known sequence of human syndecan-I (Mali ct nl, 1990) and 
human syndecan-4 (David e/ nl , 1992). Subclones were used to transform 
E coli strain DH5 alpha 6·om w hich fusion proteins linked to glu tathionc 
S-cransfera se containing the thrombin cleavage site were iso lated . Fusio n 
proteins were separated from the crude bacterial extract b)' binding to 
glutathio ne Sepharose 4B and by c1uting via thrombin cleilvage, as de-
scribed by the manufilcturer. 
Antibody Preparation and Western Blot Analyses For production of 
antibodies specific to hu miln syndecan-1 (I-ISE-1) , the recombinant human 
syndecan-l core pro tein was used for immuniza ti on of rabbits at the Pine 
Acres R abbitry/Farm (Norton, MA). R abb its were immunized in trader-
mally with 100 I-tg of syndecan-l in complete Freund's adjuvant and 
boosted subcutaneously with 100 I-tg of thrombin-cleaved syndecan-I o n 
weeks 2, 7, ilnd 12. Bleeds were performed 2 wk ilfter boosts . Po lyclonal 
antisera were prcadsorbed for 30 nun at 4°C with 10% (wt/vol) acetone 
powder deri ved &om E coli strain D H S alpha transformcd with the 
pGEX- 2T vector prior to use. For production of monoclonal antibod ies 
specific to human syndecan-4, recombinant syndecan-4 and tota l pro teo-
glycan purified from the medium of the human cell line IMR-90 were used 
for il11m unization of mice and production of monoclonal antibodies by D r. 
William Sutherland at the University of Virginia antibody preparation 
facility . Mice w ere immunized and boosted w ith a 100 I-tg mixture of 
recombinant syndeciln-l. -2, and -4 w ith a final intrasplenic boost of 
syndecan proteoglycans obta ined fro l11 IMR-90 cell cul ture. Two indepen-
dent hybridoma clones, 5G9, and 8C7, which produced antibodies reacting 
specifica ll y with human syndecan-4 fusion protein, were isolated. 
To demons trate antibod y specifi city, antibodies were tested on western 
blots of proteoglycans isola ted from conditio ned media of IMR.90 cells. To 
analyze core proteins, glycosaminoglyca n side chains were remo ved from 
proteoglycans by treatment with HS lyase (heparitinase) and chondroitin 
sulfate ABC lyase (Seikgaku Kogyo Ltd , R ockville , MD) as described 
pre viou sly (Sande rson and Bernfield, 1988) o r by nitrous acid dcamination 
(Shivel y and Conrad , 1976). 
P roteoglyca ns and core proteins we re separated on 3.5 to 17.5%, gradient 
SDS- polyacrylamide gels con taining 2.7 M urea . Proteins were transferred 
to Immobilon N membranes (Milliporc Co. , Bedfo rd , MA.) and the 
antigens detec ted by immuno blot analyses using the ECL detection system 
(Amersham , Little C halfon t. Buckinghamshirc, U.K.) . 
Polyclonal rabbit antiseru m against H SE-1 recognized an approximately 
300- kDa proteoglycan purifi ed fro m IMR-90 - conditioned medium (Fig 
lC). Following removal of HS fro m the core protein of this proteoglycan, 
HSE- l specifi ca ll y recognized an approx.imately 80-k1)a co re protein (Fig 
1V) identi ca l in size to the core protein of purified mo use syndecan-l (Fig 
iB) . Mouse m onoclonal antibody 5G9 (antibody subclass IgG2"K) recog-
nized h uman syndecan-4 and an approx imately 290-kDa proteoglycan 
purified fro m human IMR-90 - conditioned media (Fig lE) but not synde-
can- t, - 2 , or - 3 by dot b lot and ELISA analyses (data not shown) . After 
removal ofl-lS, 5G9 recognized an approximate ly 30- kDa core protein (Fig 
11'), cons istent with the size of the syndecan-4 core protein reported 
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Figure 1. Antibodies against hunta n syndecans-l and -4 are spe-
cific. Proteoglycans were untreated (Inlles A, C, flOld E) or treated (lnlles B, 
D, nlld F) to remove glycosa minoglyc:01l chains and separated on a 3.5% to 
17.5% gradient SDS gels prior to transfer and immunosta ining as described 
in il4nlerinls & Methods. Lalles A nlld R, purified mouse syndecan-l detect.ed 
with monoclonal antibody 281-2 Qalkanen cl ai, 1985} . Lnlles C-F, proteo-
glycan fractio n fro m IMR-90 cell- condi tioned m edium. Lnll l!S C nlld D , 
detection of syndecan-1 with polyclonal antisera I-ISE-1. Lillie., E flOld F, 
detection of syndecan-4 w ith monoclonal antibody SG9. Samples in Inlles R, 
D, flOld F have been trea ted with ni troLls acid to remove HS. 
previously &om human (David el nl, 1992), rat (Kojima cl nl, 1992b) , and 
mnuse (Kim <I nl. 1994). A second independently isolated monoclonal antibody 
to human syndecan-4 (8C7). antibody subclass IgG ,", had identical dot blot and 
western blot reactivity to that shown for SG9 (data not shown) . 
Mouse Wound Preparation Under general anesthesia, hair was re-
moved frol11 the backs of adult C57BL mice (Children'S H ospita l m ouse 
breeding f.,c ili ty, Bos ton, MA) , and a 1-cm full thickness incision was 
in troduced. At day I , 2, 3, 4, 5, 7, 10, and 14 post- wounding, mice were 
sacrifIced by cervical dislocati on , and the wounds were harves ted by 
excising the skin surrounding tl,e wou nd site. T issue samples were de hy-
drated in 70% ethan ol, fixed in 4% para formaldehyde . embedded in paraffin , 
and sectioned on to glass slides. 
Human Fetal Wound Preparation Human skin wounds were obtained 
as previously described (Lorenz e/ nl, 1992) after obtaining signed consent fo r 
the use of tlllS tisslle for research purposes under an approved University of 
California, San FnU1cisco, Committee On Human R esearch protocol. Briefly, 
neonatal human foreskins and 19- to 22-wk human fera l skin samples obtained 
&om therapeutic abortion material were u·ansplanted subcutaneously ont.o the 
Ranks of athYTllic ",0111" ",ice. Fetal skin and neonatal skin were grafted onto the 
contralatera l sides of the same mOuse. Seven days post-transplantation. partia l-
thickness incisional wounds were introduced OntO both skin grafts, and the 
wounds were allowed to repair. At days 1, 2. and 3 post-wounding, grafts were 
harvested, dehydrated in 70% etlmnol. fixed in 4"1., parafoll1laldehydc, embed-
ded in paraIFlIl, and sectioned onto glass slides. 
ImmunostainiJ1g o f Tissues Tissue sections we re re hydrated by step-
wise incubations through toluene. ethano l, and T ris-buffered sa line. Al l 
sections were pre-treated in antigen retrieva l solution (ll ioGencx, San 
Ramon, CAl per directio ns of the manuf.,ctllfer. T issue secti ons were 
blocked with 10% goat serum for 1 h prio r to addition of the primary 
antibody. Monoclonal antibody 28 1-2 Galkanen cl nl, 1985} and polyclonal 
antisera MSE-2 , MS.E-3, and MSE-4 (Kim el II I, 1994) di lu ted 200-fo ld in 
Tris-bu ffe red saline with 0.1 % BSA (TBS13), were used to detect mouse 
syndecan-l, - 2, -3, and -4, respecti vely. T he polyclonal antiserum, HSE-1.. 
diluted 1000- fo ld , was used to detect human syndecan-1 . 5G9 monoclonal 
antibody (0. 14 mg per ml) or 8C7 (0.1 0 mg per ml) was used to detect 
human syndecan-4. Primary antibodies wem incubated overnig ht at 4°C . 
After washing with T13S, biotin-conjugated goat anti-rabbit IgG (H and L 
chains) Or biotin-conjugated goat anti-mouse IgG (H and L chains), botll 
purchased trom Kirkegaard & Perry (Ga ithersburg, MD), were dilu ted 
·IOOO-fo id in T OSB and applied to sections for .) h at room temperature. 
Staining was performed using the Vectastain ABC kit (Vector Laboratories, 
Inc. , Burlingame, CAl. Sections wer further counter-stained w ith H arris' 
hem"toxylin (Lerner Labs. Pittsbllfg PAl and mo unted with Permou l1t 
(Fisher Scientific, Fairlawn. NJ). 
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Figure 2. Syndecan-l and -4 but not -2 and -3 are induced during murine skin wound repair. Adult murine skin 3 dafter incisional injury was 
stained with antibodies specific for syndecan-l , - 2. -3 , or -4 (n-d) or control antibodies to (e-J) and then counter-stained with hematoxylin. Smnll mTDII1S 
indicate wound margin . (n) Mouse skin sta ined with monoclonal antibody 28 1-2 specifi c for syndecan-1. Lnrge mTO'I' indicates expression on endothelia . (e) 
Irrelevant monoclonal antibody contro l for syndecan-l . (b) Polyclonal antibody direc ted against syndecan-2 shows no apparent staining . (j) Pre-immune 
control for syndecan-2. (e) Polyclonal antibody di(Ccted against syndecan-3 shows no apparent staining. (g) Pre- immune control for syndecan-3. (d) Polyclonal 
antibody directed ag'linst syndecan-4 show s expression of syndecan-4 in the epidermis and iII great abundance within the dermis at the wound margin . (b) 
Pre-immune control for syndecan-4. See Figs 2 and 3 for higher magnifi ca tion of syndecan-I and -4 sta ining. Adjacent sec tions are shown from one 
cxperinlCllt re presentative of fi ve cxpcrinlcnts. Scnle bnr1 40 lUll. 
Morphometric Analyses Syndecan-l and -4 expression iII human skin 
was anal yzed by counting the proportion of immunostained cells in four 
distinct fie lds at 200 X magnification. A minimum of 200 cell s were 
eva luated from each graft. A feta l skin graft and a contra latera l neonatal skiIl 
g raft w ere eva luated at 1, 2, and 3 d after injury in each experiment, and 
these experiments were repeated three times. India ink was used at time of 
injury to identify the wound edge (Lorenz c/ nl. 1992). Ce ll s adjacent to the 
wound were defined as those w ithin approximately 200 /Lm of the wound 
edge and cell s distal to the w ound as those greater than 200 fJ..m from the 
wo und edge. R esults 'Ire expressed as the to tal sta ined cells divided by the 
tota l cells in a 200 X fie ld . Statistica l signifi cance was dete rmined by 
Student' s t test (Brown and Hollander, 1977) . 
RESULTS 
Syndecan-l and -4 Are Selectively and Transiently Induced 
in Mouse Skin During Wound Repair To compare expression 
of syndecan-l, - 2, -3, and -4 during wound repair, adult mouse skin 
was wounded and allowed to repair. At various times post-injury, 
wounded tissues with surrounding normal slcin were harvested and 
UllmlUlostained for syndecan-1 , -2, -3, and -4 expression. In nonnal 
unwounded mouse skin, syndecan-1 was expressed abundantly on 
surfaces of epiden1lal keratinocytes and follicular epithelia but was not 
detectable on endothelial cells or detmal fibroblasts as previously 
reported (Hayashi e/ ai, 1987). Syndecan-l was induced Ul the 
granulation ti ssue adjacent to tlle wound and was seen pt;marily on 
endothelial cells (Figs 2A; 3A), consistent witll previous observation 
(Elenius e/ ai, 1991). Syndecan-l was not detected in endothelial cells 
or fibroblasts in n0I11131 slcin distal from the wound. This wOlUld-
specific ulduction was transient; nonna] express ion retumed by day 1-1 
post-wOlUlding w hen the repair is nearly complete (data not shown). 
The remaining members of the syndecan family of HSPG 
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Figure 3. Syndecans-l and -4 are expressed on epidermal kerati-
n ocytes of injured mouse skin. Higher magnifica tion of hyperprolifera-
rive epidermis in wounded skin shown in Fig 2 . (n) Expression of 
synd ecan-l detected with monoclonal antibody 281-2. (e) Irrelevant anti-
body control for s)'ndecan-l (b) Polyclonal antibod), directed against 
syndecan-4. (d) Pre-immune control fo r syndccan-4. Syndecrul-l surrounds 
stratified kerarinocytes throughout the epidennis but is absent from the 
basem e n t membrane region of the basa l keratinocytcs. Syndecan-4 is 
predoLninantly expressed on keratinocytes at the basal cell layer including 
the surface adjacent to the basement membrane. A n-ows indicate basement 
membrane zone. Scale bnr, 40 um . 
showed a diffe rent respon se to injury. N e ither syndecan-2 no r -3 
was d e t ected in normal o r w ounded skin (Fig 2B,q, although 
these antibo dies successfully detected syndecan-2 and - 3 o n wes t-
em bl o t (Kim el Ill, 1994) and in simi larl y p repared 16-d m ouse 
embryo s (data no t sho wn). Murine fib roblas ti c cells are known to 
express syndecan-2 and - 3 at low levels in culture (K in1 e ( 11/1994), 
and l ack o f d e tectio n here refl ec ts thi s lo w expressio n and perhap s 
the insen siti vity o f ti ssue stainin g . 
Synd ecan-4 w as detecte d prim aril y o n bas ilar ke ra tinocytes o f 
hyperprolife rative epidermis after injury (Fig 3B) . In the d ermis, 
synde can-4 was no t detected in n orm al skin distal to the site of 
injury but w as induced o n these d ermal ce lls and d e tected in grea t 
abunda n ce in the g ranulatio n ti ssue adjacen t to the wound (Fig 
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F igure 4. Syndecan-l and -4 are induce d in dermal cells of the 
IDurine wound. Higher magni fica tion from Fig 2 of dermis stained for 
s)' lldccan-l and -4. (a) Endothelial cells stained for syndecan- l with 
monoclonal rul ribody 281 - 2 (large (//,-0111) (e) Irrelevant COHtrol fo r s)'11de-
can-1. (b) Endothelial and fi broblastic ce lls throughout dermis stain with 
polyclonal antibody to s)'11decan-4. (d) Pre-immune control for syndccan-4. 
Senle bar, 40 lim. 
2D) . In con tras t to the localized endo the lial stanung for synde-
can- i, syndecan-4 staining was increased th rougho u t th e demu s at 
the wound ed ge (Fig 4B, Fig. 5). T lus in crease in syndecan- 4 
expressio n was o n bo th endothe lial cells and non endo thelial cells 
o ccupying the granulation tissue . T he wound-specific induc tio n of 
sYl1decan-4 was transient, appearing as early as 12 h post-wound-
ing, peaking at d ay 3 p ost-wounding, and returnin g to b asal levels 
by day-1 0 p ost wounding (Fig 5) . In no rmal un inj ured epidemus 
the stratification of syndecan-4 staining presen t in hy perpro lifera -
tive w o w1ded epidermis was not apparen t. 
Syndecan-l and -4 Are Induced in Human Neonatal Skin 
During Wound Repair To evalua te syndecan expression dur -
ing human wound repai r , human fo reskins grafted subcutaneously 
into athymic 1111 / 1111 mice were wounded and allowed to repair. At 
1 , 2 , and 3 d post- wounding, graft samples were harvested and 
im mul10stained w i th antibo dies specific fo r sYlldecan- i and - 4. 
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Figure 5. Expression of syndecan-4 during murine wound repair is 
transient. Expression of syndecan-4 was evaluated prior to injury (a), and 
12 h (b), 3 days (c), or 12 days (d) after incision.1 injury. Syndecan-4 is firSt 
observed at the wound margin (mTo",s) 12 h after injury (b). Three days 
foUowing il~Ury, expression of syndecan-4 is throughout the granulation 
tissue (c) (asterisks). Twelve days foUowing injury re-epithelialization is 
complete and expression of syndecan-4 in the repaired dermis (m1"Dw) has 
diminished to background (d) . Apparent staining of stratum corneum and 
sebaceous glands is nonspecific and was also observed in pre-immune 
control sections. Data are from four aninlals in one experiment represen_ 
tative of three experiments. Scale bar, 40 um. 
In neonatal human skin transplanted subcutaneously into Ilu/Ill/ 
mice, syndecan-l was detected in a pattern identical to that 
described in murine skin wound repair. Abundant expression was 
seen on surfaces of epidermal keratinocytes (data not shown) but 
was not detectable on endothelia (Fig 6A). Following injury, 
syndecan-l was induced primarily on endothelial cells at the wound 
margin (Fig 6B). 
In contrast to the undetectable levels of expression of syndecan-4 
in mouse dermis, syndecan-4 was detected on some cells in the 
dermis in unwounded neonatal human skin grafts (Fig 6D) . 
Following injury, more endothelial cells in neonatal skin expressed 
syndecan-4 adj acent to the wound than in unwounded skin (Fig 
Figure 6. Syndecan-l and -4 are induced on endothelia in neonatal but not fetal human skin wounds. Neonatal or 19-wk fetal human skin were 
transplanted into nude mice and stained for syndecan-l expression (a -c) or syndecan- 4 expression (d-j) and counter-stained with hemato>."lin. Dennal vessels 
in uninjured neonatal skin (a, d). Two days after injury, vessels in neonatal skin adjacent to the wound stain abundantly (b, e) but vessels in fetal skin adjacent 
to the wound show no increase in staining (c, j). Similar results were obtained in three experiments and at 1 and 3 d post-injury. Scale bar, 40 um. 
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Figure 7. Injury increases the proportion of cells staining for 
sy.nd e can-l and - 4 in neonatal but not fetal ski.n. Morphometric 
analysis of syndecan-I and syndecan-4 expression on dermal cell s i iI 
neonataJ and fetal skiJI 2 d aftcr injury. Solid bnrs arc data dcrived ITom 
observation of syndecil ll sta ining on cells adjacent to the woulld. Opel/ bnrs 
are data dcrived fi'om observation of cells sta illjllg for syndecans in skin 
distal to the wOll nd . Data shown arc rnean of eight 111caSUrCITIcnts in n¥o 
independent grafts ::': SD. Similar resul ts we re observed at 1 'lIld 3 dafter 
injury. * = P < 0.001, Student's t test. 
6E). Because the unwounded dermis of human skin stained for 
syndecan-4, however, the wound-specific induction of syndecan-4 
on d e mlal cells was less apparent than in the m o use. Morphometric 
analysis of syndecan-1 and -4 on neonatal dermal cells adjacent to 
the wound demonstrated an in crease in express ion of syndecan-l 
and syndecan-4 on endothelial and non endo thelial ceIJs of the 
dernrtis (Fig 7) . T his increase in syndecan -1 and -4 was present in 
the neon ata l dermis at all times examined . 
Syndecan-1 and - 4 Arc Not Induced During Human Fetal 
W ound Repair T he behavior and fin al organization of ceIJs in 
the dernUs differed in fe ta l and neona ta l wound repair. Unlike 
) neonatal or adult skin , fetal skin prior to 22 wk gestation lacks an 
apparen t scar fo llowin g injury (Lorenz el ai, 1992). To compare the 
regulation of syndecan-1 and - 4 express ion during wound repair of 
neonatal and feta l skin , g rafts of human fe tal skin were implanted in 
the flank opposite to the grafts of human n eonata l skin . Fetal and 
neonatal skin were trea ted identically during and after subcutan e-
ous transplan tation . Express io\l of syndecan-1 and - 4 diftc red in 
wo unded feta l skin compared to wounded neon ata l skin. N o 
indu ction of syndecan-t was detected in dermal endo the lia during 
repair of fetal dennis (Figs 6C; 7). As noted for neon ata l skin, 
syndeC3J1-4 was detected on many cells in feta l dermis prio r to 
injury. As with syndecan- l , however, no indu ction of syndecan -4 
was seen on fetal dermal ceIJs after injury (Figs 6F; 7) . 
DISCUSSION 
Synd ecans, cell surface H SPGs, can influence cell behavior by their 
interac tions with g rowth fac to rs, extracell ular matrix , proteases, 
protease inhibitors, and other cell surface molecules (Bernfield el al. 
1992; Rapraeger, 1993) . Syndecan fa mil y m embers are distinctly 
expressed during embryogenesis (Trautman ef nl, 1991 ; Gould el ai, 
1992; David el ai, 1993) and in adult tissues (Kim el ai, 1994), 
suggesting that tlley arc differentially regulated . In this paper, we 
demonstrate that during botll adult murine and neonatal human 
cutaneous wound repair, syndeca n-1 and syndeca n-4 are transiently 
and dis tinctly induced in the wound. Feta l human skin lacks the 
fi brosis a nd scar fo und w hen neonatal or adult skin heals. We find 
that fetal human skin also docs not show in creased syndecan 
expression afte r injury. T hese observations, combined w ith our 
current understanding of HSPG fun ctions. suggest that syndecans 
can infl u en ce wound repair and may influence the derm al reorga-
nization that leads to fibrosis and scar. 
Observations of an ini tial increase and the subsequent decrease in 
the cell surface express io n of syndecan-l and - 4 foll owing injury 
are based upon the ability to detect the extracellular domain of 
syndecan - 1 and -4 core proteins. Altho ugh structurally similar, the 
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extracellular domains of th e syndecan core prote ins diffe r between 
human and mouse . T he reagents used for detection of murine 
syndecan-1 and - 4 were not useful for detec tio n of their hu man 
hom o logs . To evalu ate the human syndecans, we prepared rabbit 
anti-hum an syndecan- l polyclon<ll antisera an d two diffe ren t 
m onoclonal m o use anti-human syndecan- 4 antibodies . T hese anti-
bodies were shown to be specific for syndecan- l o r - 4 by weste rn 
blot and successfully de tected the syndecans in fo rnla lin-fixed 
hum an skin. 
Syndecan Induction in Wound Repair T he syndecan family 
has been found to consist of four distin ct gene products. We and 
oth ers (Elenius el ai, 1991 ) have found syndecan- 1 to b e indu ced on 
vessels w ithin the granulation tissue of the m o use wound . T hus, it 
became important to understand the potential contl"ibution of other 
syndecans to the wound repair process . No change in the expres-
sion of syndecan-2 (a lso known as fibroglycan) or syndecan -3 was 
detected during m urine wound repair. Syndecan-4 (also known as 
ryudoc3n, 3mphiglycan) bas been identi fied in the rat (Koj ima el ai, 
1992b), chick (Baciu ei ai, 1994), m ouse (Kim el ai, 1994), and 
human (Kojima el ai, 1992b) . In normal un wounded murin c skin, 
we detected the presence of syndecan-4 o nly in the epidermis. As 
early as 12 h afte r injury, however, syndecan-4 appeared in great 
abundance in th e granulation tissu e and throughout the dermis at 
the wound edge. T he re lative am o unt and loca lization of synde-
can- 4 were much greate r and widespread than observed for syn-
decan-1 in adjacent sections fi'o m identical mouse WO UJlds. 
Our observations of syndecan-1 and -4 induction after injury of 
neonatal human skin were simil ar to those seen in repairipg m o use 
skin. In neon ata l human skin , like that of adul t m ouse, sYlldeca n-l 
was abundantly de tected in vessels at the WOlll1"d edge. U nl ike til e 
m o use, in human skin stain ed with e ither of two sepa rate mono-
clonal anti- sYll dccan-4 antibodies, syndecan-4 was de tected in 
som e ce lls prim' to injury. T his fi nding is consistent with the 
ubiqui tous express ion of syndecan-4 found in cul tured cells and 
w h ole tissues (Kim el ai, 1994) but d iffe red from the e"'Pression 
de tected in mouse using an anti-syndecan-4 rabbit polyclonal 
antibod y. T his diffe rence in appar ent constitutive expression of 
syndecan-4 m ay re fl ec t d ifferen t expression patterns of syndecan-4 
between species or may be th e resul t of using m ore sensitive 
antibodies on th e human sections. Nevertll e less, an increase in 
syndecan-4 could be detected after injury in both adu lt mouse and 
neonatal human dermal cells. 
T he selective in crease in two of the four kn own syndecan fa mily 
members correlates w ith our prior observations of tile action of a 
syndecan-inductive peptide, PR-39 (Ga ll o el ai, 1994). PR-39 is 
present in neutrophils of early porcine partial thickness wounds and 
is fo und in porcine wound flu id. The peptide selectively ind uces 
cul tured murin e endothelial and fib roblastic ce ll s to increase tran-
script abundance and cell surf.,ce expressio n of sYlldecan-l and 
syndecan-4. This syndecan-inductive activity is only present during 
the early phase of wOlU1d repair (Gallo CI ai, 1994). We now find 
tha t indu ction ofsYlldecan-l and-4 ;11 /1;/10 also occurs only early and 
transiently on endoth elia l and fi broblastic cells at the wound edge. 
T his was most d ramatic for syndecan-4 in the m o use; pr.io r to 
re-epithelialization, the entire dermis stains strongly for synde-
can-4. After repair of the epide rnlis is complete, and the in flam-
matory infi ltrate diminishes, syndecan-4 express ion in the dermis 
declines to baseline levels. T hus, the detection of an increase in 
syndecan-l and -4 ;11 /1;110 is consistent with tile presen ce of an 
inductive facto r(s) re leased by cells in the early inflammatory 
infi ltra te and agrees with prior observations ;11 1) ;11'0 of the action of 
PR-39 in mesenchymal cells. 
Syndecan Expression and Changes in Cell Behavior T here 
is much ;11 11;1)0 evidence to suggest that sYlldecan expression can 
change cell behavior. Expression of syndecan-l in the develo ping 
mouse embryo fo llows morphogenetic patte rn s and changes as ce ll 
behaviors change (Sutherland el ai, 1991). D uring organ ogenesis 
sYlldecan-l is lost fi'o m epithelia w hil e th ey change shape and is 
concurrently induced in adjacent condensed l11 esenchYln e (Traut-
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m an ct ai, 1991). Mammary epithelial cells that have decreased 
syndecan- l expression by transfec tion with an ti-sense syndecan-1 
cDN A have rearra nged {31 in tegrins and become fu siform (Kato et 
ai, 1995). Conversely, increased expressio n of cell surfuce synde-
can- l can induce fusiform Sch wal1l1 cells to spread and adopt a 
more "epithelioid" phenotype (Carey et ai, 1994) . T he m echanism 
of th ese changes in ceil behavior and ph enotype is unkn own , but 
the abili ty of HSPGs, li ke syndecan-l, to bind to multip le compo-
nents of the extrace llul ar matrix (Demfield et ai , 1992) and to 
growth facto rs such as fi brobl as t grow th factors (FGFs) may explain 
this behavior. 
In the dermis both adult m ouse and neonatal human skin wounds 
show a large increase in the am o unt of sYlldecan-1 and -4 . T his 
increase in cell surface HSPGs predicts a large change in the abili ty 
of these cells to associate with heparin-binding molecules that affec t 
cell behavior. For example, FG F-2, vascula r endothelial growth 
factor, and heparin-binding epiderm al growth factor have been 
iden tified in wounds, and their fun ction is dependent upon binding 
to ce ll surface HSPG (Klagsbrun and B aird, 199 1; Drown et ai, 
1992; Gitay- Goren e/ ai, 1992; Werner et ai, 1992; Marikovsky ct ai , 
1993; R eich-Slotky e/ ai, 1994). Interes tingly, the location o f 
induced vascular endo thelial growth fac tor during wound repair 
closely mimics that of syndecan- l. Doth syndecan-l (Yamagata ef 
ai, 1993) and syndecan-4 are in focal adhesions (Woods and 
Couchman, 1994), and change in their express io n during injury 
may refl ect changes in cell m otility . 
Syndecan Induction and Fetal Skin Repair Lack of increased 
expressio n of the syndecans in irtiured fe tal skin has important 
implications for understanding wound repair. In repairing fetal 
tissue, proli fe ration of endothelial cells, fi broblasts, and epithelial 
cells must occur bu t, in contrast to mouse or neonatal skin, these 
even ts are not associated with syndecan induction . T his lack of 
syndecan inductio n m ay be interpreted in several ways; other 
HSPGs may function in the fe tal skin , constitutive expression of 
syndecans may be sufficie nt for actio n, H S may change w ithou t an 
increase in core pro tein expression , or other growth facto rs that do 
not involve syndecans may be expressed in fe tal ski n . For example, 
other HSPGs, such as perlecan or members of the glypican family, 
could facilitate the action o f heparin-binding growth fac tors in the 
fetal wound . Embryonic neural tissue has also been shown to 
con tain HSPG that chan ges abili ty to bind FGF-1 through a change 
in HS chains (N urcombe ef ai , 1993). Finally, the heparin-binding 
growth facto rs FGF-2 and PDGF are exp ressed differently during 
fetal and adult wound repair (Whitby and Ferguson , 1991) , and 
their action may be independent of syndecan expression . 
A function of syndecan induction may be to mediate cellular 
behaviors tha t differ between fetal and adul t wound repair. T he 
repa ir of fe tal skin may u tilize to a lesser exten t those p rocesses or 
molecules that are poten tially regul ated by cell surface syndecans, 
e.g., proteases such as elastase and cathepsin G (Redini ef ai , 1988; 
Erm olieff ef ai , 1994) , pro tease inhibi tors such as anti-thrombin III 
(Danielsson ef ai, 1986), cell adhesion mo lecules such as Mac-1 
(D iam ond et Il l , 1995), and extracellular matrix molecules such as 
collagens and fi bronectin . Minimal involvem ent of these or other 
m olecules could lead to the diminished fib rosis and scars that 
charac terize fetal wound repair . 
In summary, this study has shown that syndecan-1 and synde-
can-4, molecules thought to be critical to the regulation of cell 
behavior dudng developmen t, are induced during cutaneous 
wound repair in murine and human skin . Syndccan-1 and -4 
localize di fferently in the wound and are induced on difle rent cell 
types. T he inductive phenomenon is entirely absen t during wound 
repair in human feta l skin . T lus lack of induction suggests tha t the 
increase in ceil surface syndecans is not an absolute requirement fo r 
w o und repair. T he correlation between syndecan induction and 
scarring during w ound repair also sugges ts that the syndecans m ay 
modify the repair process through interactions w ith heparin-bind-
ing m olecnles in the wound microen vironment that enh an ce 
fi brosis. T hus, through control of the expression of syndecans 
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during injury, it may be possible to simuJtan eously influe nce 
multiple cellular behaviors and thus the o utcome o f the wound 
repair process . 
T his lIIork lIIas sllpported by Naf ioll al Illstitlltes oj Health Grnllts A R01874 (to R. 
L. G.) a/ld CA28735, HD0673, alld H L-46491 (to M. B.) alld a grallt ji-Olll 
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